MDA-19 4-hydroxybenzoyl metabolite (Synonyms: BZO-HEXOXIZID 4-hydroxybenzoyl metabolite) |
| Catalog No.GC52440 |
An Analytical Reference Standard
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
MDA-19 4-hydroxybenzoyl metabolite is an analytical reference standard that is structurally similar to known synthetic cannabinoids. MDA-19 4-hydroxybenzoyl metabolite is a potential metabolite of MDA-19 based on the published metabolism of 5-fluoro CUMYL-PINACA and CUMYL-PeGACLONE .1,2 At the time MDA-19 4-hydroxybenzoyl metabolite was made available for purchase, specific metabolism data had not been published. Contact us if updated information on this molecule is now available. This product is intended for research and forensic applications.
1.Staeheli, S.N., Poetzsch, M., Veloso, V.P., et al.In vitro metabolism of the synthetic cannabinoids CUMYL-PINACA, 5F-CUMYL-PINACA, CUMYL-4CN-BINACA, 5F-CUMYL-P7AICA and CUMYL-4CN-B7AICADrug Test Anal.10(1)148-157(2018) 2.Mogler, L., Wilde, M., Huppertz, L.M., et al.Phase I metabolism of the recently emerged synthetic cannabinoid CUMYL-PEGACLONE and detection in human urine samplesDrug Test Anal.10(5)886-891(2018)
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *